Epileptic seizures in diffuse low-grade gliomas in adults

Brain

Volumn 137, Issue 2, 2014, Pages 449-462

  Pallud, Johan ^a,b,c,d   Audureau, Etienne ^b,e   Blonski, Marie ^c,f   Sanai, Nader ^g   Bauchet, Luc ^c,h   Fontaine, Denys ^c,i   Mandonnet, Emmanuel ^c,j   Dezamis, Edouard ^a,b   Psimaras, Dimitri ^k   Guyotat, Jacques ^c,l   Peruzzi, Philippe ^c,m   Page, Philippe ^a,b   Gal, Beatriz ^d,n   Párraga, Eduardo ^a,b   Baron, Marie Hélène ^c,o   Vlaicu, Michaela ^k   Guillevin, Rémy ^c,p   De'aux, Bertrand ^a,b   Duffau, Hugues ^c,h   Taillandier, Luc ^c,f   Capelle, Laurent ^c,k   Huberfeld, Gilles ^d,k   more..

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Réseau d'Etude des Gliomes REG   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^e HÔTEL DIEU   (France)

^f Nancy Neurological Hospital   (France)

^g Barrow Neurological Institute   (United States)

^h GUI DE CHAULIAC HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF NICE   (France)

^j HÔPITAL LARIBOISIÈRE   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l HÔPITAL NEUROLOGIQUE   (France)

^m REIMS UNIVERSITY HOSPITAL   (France)

ⁿ UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^o UNIVERSITY HOSPITAL OF BESANÇON   (France)

^p UNIVERSITÉ DE POITIERS   (France)

more..

Author keywords

diffuse low grade gliomas; epileptic seizures; predictors; prognosis; surgery

Indexed keywords

ANTICONVULSIVE AGENT; CONTRAST MEDIUM; MOLECULAR MARKER; TEMOZOLOMIDE;

ADULT; ADULT DISEASE; ANTICONVULSANT THERAPY; ARTICLE; ASTROCYTOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSE LOW GRADE GLIOMA; FEMALE; GLIOMA; GROWTH RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY (TOPIC); NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SEIZURE;

DIFFUSE LOW-GRADE GLIOMAS; EPILEPTIC SEIZURES; PREDICTORS; PROGNOSIS; SURGERY;

ADULT; BRAIN NEOPLASMS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84893825333     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt345     Document Type: Article

References (41)

1. Bauman G, Fisher B, Watling C, Cairncross J, Macdonald D. Adult supratentorial low-grade glioma: Long-Term experience at a single institution. Int J Radiat Oncol Biol Phys 2009; 75: 1401-7
2. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994; 74: 1784-91
3. Berger MS, Ghatan S, Haglund MM, Dobbins J, Ojemann GA. Lowgrade gliomas associated with intractable epilepsy: Seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg 1993; 79: 62-9
4. Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 2003; 14: 1715-21
5. Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, et al. Glutamate release by primary brain tumors induces epileptic activity. Nat Med 2011; 17: 1969-74
6. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 2008a; 108: 227-35
7. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, et al. Preoperative prognostic classification system for hemispheric lowgrade gliomas in adults. J Neurosurg 2008b; 109: 817-24
8. Danfors T, Ribom D, Berntsson SG, Smits A. Epileptic seizures and survival in early disease of grade 2 gliomas. Eur J Neurol 2009; 16: 823-31
9. de Groot M, Reijneveld JC, Aronica E, Heimans JJ. Epilepsy in patients with a brain tumour: Focal epilepsy requires focused treatment. Brain 2011; 135: 1002-16
10. De Witt Hamer PC, Gil Robles S, Zwinderman AH, Duffau H, Berger MS. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: A meta-Analysis. J Clin Oncol 2012; 30: 2559-965
11. Englot DJ, Berger MS, Barbaro NM, Chang EF. Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 2011a; 115: 240-4
12. Englot DJ, Han SJ, Berger MS, Barbaro NM, Chang EF. Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors. Neurosurgery 2011b; 70: 921-8
13. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-2
14. Frenay MP, Fontaine D, Vandenbos F, Lebrun C. First-line nitrosoureabased chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomas. Eur J Neurol 2005; 12: 685-90
15. Gerin C, Pallud J, Deroulers C, Varlet P, Oppenheim C, Roux F-X, et al. Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas. Neuro Oncol 2013; 15: 1379-88
16. Haglund MM, Berger MS, Kunkel DD, Franck JE, Ghatan S, Ojemann GA. Changes in gamma-Aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg 1992; 77: 209-16
17. Hildebrand J, Lecaille C, Perennes J, Delattre J-Y. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 2005; 65: 212-5
18. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004; 22: 3133-8
19. Huang L, You G, Jiang T, Li G, Li S, Wang Z. Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: A preliminary study. J Neurol Sci 2011; 302: 63-7
20. Jakola AS. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas surgical resection vs waiting in low-grade gliomas. JAMA 2012; 308: 1881-8
21. Klein M, Engelberts NHJ, van Der Ploeg HM, Kasteleijn-Nolst TrenitéDGA, Aaronson NK, Taphoorn MJB, et al. Epilepsy in lowgrade gliomas: The impact on cognitive function and quality of life. Ann Neurol 2003; 54: 514-20
22. Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, et al. Temozolomide chemotherapy for progressive low-grade glioma: Clinical benefits and radiological response. Ann Oncol 2003; 14: 1722-6
23. Pallud J, Capelle L, Huberfeld G. Tumoral epilepsy. How does it happen? Epilepsia 2013; in press
24. Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R, et al. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro-Oncology 2009; 11: 176-82
25. Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin R, Galanaud D, et al. Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol 2006; 60: 380-3
26. Pallud J, Taillandier L, Capelle L, Fontaine D, Peyre M, Ducray F, et al. Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma. Neurosurgery 2012; 71: 729-40
27. Pallud J, Varlet P, Devaux B, Geha S, Badoual M, Deroulers C, et al. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology 2010; 74: 1724-31
28. Pignatti F, van Den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002; 20: 2076-84
29. Rogers LR, Morris HH, Lupica K. Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology 1993; 43: 1599-601
30. Ruda R, Bello L, Duffau H, Soffietti R. Seizures in low-grade gliomas: Natural history, pathogenesis, and outcome after treatments. Neuro Oncol 2012; 14: Iv55-64
31. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008; 62: 753-64
32. Sawaya R, Hammoud MA, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998; 42: 1044-55
33. Senner V, Köhling R, Püttmann-Cyrus S, Straub H, Paulus W, Speckmann E-J. A new neurophysiological/neuropathological ex vivo model localizes the origin of glioma-Associated epileptogenesis in the invasion area. Acta Neuropathol 2004; 107: 1-7
34. Sherman JH, Moldovan K, Yeoh HK, Starke RM, Pouratian N, Shaffrey ME, et al. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg 2011; 114: 1617-21
35. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al. Role of extent of resection in the long-Term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008; 26: 1338-45
36. Soffietti R, Baumert BG, Bello L, Deimling Von A, Duffau H, Frénay M, et al. Guidelines on management of low-grade gliomas: Report of an EFNS-EANO. task force. Eur J Neurol 2010; 17: 1124-33
37. van Breemen MSM, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: Epidemiology, mechanisms, and management. Lancet Neurol 2007; 6: 421-30
38. van Den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al. Long-Term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet 2005; 366: 985-90
39. Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001; 42: 282-6
40. You G, Sha Z-Y, Yan W, Zhang W, Wang Y-Z, Li S-W, et al. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: A clinicopathological study. Neuro Oncol 2012; 14: 230-241
41. Yuan Y, Xiang W, Yanhui L, Ruofei L, Shuang L, Yingjun F, et al. Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control. Seizure 2013; 877-81